WHO WE ARE

HKboenchem was established in Hong Kong in 2020. We are an innovative high-tech enterprise integrating R&D and sales.
The company has built a variety of dry chemical platforms, immunodiagnostic platforms, molecular diagnostic platforms and biological raw material platforms, constantly enriching the demand menu in medical testing fields such as endocrine diseases, infectious diseases, prenatal and postnatal care, tumors, and genetic diseases, and continuing to serve hospital systems at all levels , blood centers, CDCs, independent hospital laboratories and other medical institutions.
We have innovative technologies for key intermediates, small molecule CDMO, FTE, FFS, pharmaceutical composition analysis, and chiral drugs.
We have a platform that respects talents, values performance, and continues to innovate. Here, all talents can maximize their strengths, achieve themselves and the company.